6 Biotechnology Stocks to Buy Now

Six biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

La Jolla Pharmaceutical Company (LJPC) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. In Portfolio Grader’s specific subcategories of Earnings Momentum and Earnings Revisions, LJPC also gets A’s. For more information, get Portfolio Grader’s complete analysis of LJPC stock.

Incyte Corporation (INCY) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Incyte is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. For more information, get Portfolio Grader’s complete analysis of INCY stock.

This is a strong week for Ambit Biosciences Corp. (AMBI). The company’s rating climbs to B from the previous week’s C. For more information, get Portfolio Grader’s complete analysis of AMBI stock.

Progenics Pharmaceuticals, Inc. (PGNX) improves from a C to a B rating this week. Progenics Pharmaceuticals develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. For more information, get Portfolio Grader’s complete analysis of PGNX stock.

Celladon Corporation (CLDN) boosts its rating from a B to an A this week. For more information, get Portfolio Grader’s complete analysis of CLDN stock.

Applied Genetic Technologies Corp. (AGTC) earns a B this week, jumping up from last week’s grade of C. For more information, get Portfolio Grader’s complete analysis of AGTC stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/08/6-biotechnology-stocks-to-buy-now-ljpc-incy-ambi-3/.

©2021 InvestorPlace Media, LLC